Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Jun. 30, 2020
Cash flows from operating activities:      
Net income $ 420,142 $ 346,396  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 80,066 98,588  
Loss (gain) on unrealized foreign exchange and other (12,907) 10,313  
Asset impairment charges   2,481  
Stock-based compensation expense 26,992 26,944  
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:      
Accounts receivable 73,000 (75,214)  
Inventories (85,991) (5,091)  
Other assets 5,103 (8,930)  
Accounts payable (9,822) 18,885  
Deferred system revenue (82,633) (4,833)  
Deferred service revenue (3,646) (4,337)  
Other liabilities 101,002 91,043  
Net cash provided by operating activities 512,171 496,245  
Cash flows from investing activities:      
Proceeds from sale of assets 1,114 0  
Business acquisitions, net of cash acquired 0 (78,530)  
Capital expenditures (55,925) (32,566)  
Purchases of available-for-sale securities (231,821) (263,767)  
Proceeds from sale of available-for-sale securities 53,249 25,449  
Proceeds from maturity of available-for-sale securities 95,835 198,751  
Purchases of trading securities (18,630) (9,021)  
Proceeds from sale of trading securities 21,244 11,905  
Proceeds from other investments 614 1,086  
Net cash used in investing activities (134,320) (146,693)  
Cash flows from financing activities:      
Repayment of debt (50,000) 0  
Common stock repurchases (187,897) (228,496)  
Payment of dividends to stockholders (141,164) (121,636)  
Issuance of common stock 0 114  
Tax withholding payments related to vested and released restricted stock units (25,145) (23,538)  
Payment of contingent consideration payable 0 (57)  
Net cash used in financing activities (404,206) (373,613)  
Effect of exchange rate changes on cash and cash equivalents 7,766 (3,585)  
Net (decrease) increase in cash and cash equivalents (18,589) (27,646)  
Cash and cash equivalents at beginning of period 1,234,409 1,015,994 $ 1,015,994
Cash and cash equivalents at end of period 1,215,820 988,348 $ 1,234,409
Supplemental cash flow disclosures:      
Income taxes paid 54,185 19,862  
Interest paid 40,071 26,347  
Non-cash activities:      
Contingent consideration (receivable) payable - financing activities (2,987) 9,366  
Dividends payable - financing activities 391 1,552  
Unsettled common stock repurchase - financing activities 6,000 8,000  
Accrued purchases of land, property and equipment - investing activities $ 23,388 $ 16,074